We are live on ! Find out more
WIA

Wealthstreet Investment Advisors Portfolio holdings

AUM $3.71M
1-Year Est. Return 13.1%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+13.1%
3 Year Est. Return
+75.79%
5 Year Est. Return
10 Year Est. Return
AUM
$857M
AUM Growth
+$74.4M
Cap. Flow
+$16.5M
Cap. Flow %
1.93%
Top 10 Hldgs %
25.43%
Holding
353
New
18
Increased
76
Reduced
99
Closed
3

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.8M
2
UNH icon
UnitedHealth
UNH
+$661K
3
CVX icon
Chevron
CVX
+$653K
4
NTNX icon
Nutanix
NTNX
+$554K
5
LLY icon
Eli Lilly
LLY
+$545K

Sector Composition

Rank Sector Weight
1 Healthcare 18.24%
2 Technology 15.78%
3 Financials 11.55%
4 Industrials 10.57%
5 Consumer Staples 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBK icon
101
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.3B
$1.93M 0.22%
9,688
+1,544
+19% +$293K
XBI icon
102
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$1.92M 0.22%
20,169
LVS icon
103
Las Vegas Sands
LVS
$29.9B
$1.9M 0.22%
27,490
YUM icon
104
Yum! Brands
YUM
$42.1B
$1.87M 0.22%
18,562
-100
-0.5% -$10.4K
GM icon
105
General Motors
GM
$75.8B
$1.85M 0.22%
50,644
-160
-0.3% -$5.81K
BX icon
106
Blackstone
BX
$107B
$1.84M 0.21%
32,846
SWK icon
107
Stanley Black & Decker
SWK
$15.1B
$1.79M 0.21%
10,804
AGIO icon
108
Agios Pharmaceuticals
AGIO
$2.03B
$1.76M 0.21%
36,900
+4,400
+14% +$166K
DD icon
109
DuPont de Nemours
DD
$18.6B
$1.75M 0.2%
21,673
-402
-2% -$33.4K
VZ icon
110
Verizon
VZ
$209B
$1.71M 0.2%
27,803
BRK.B icon
111
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.7M 0.2%
7,524
+200
+3% +$43.4K
SRPT icon
112
Sarepta Therapeutics
SRPT
$2.06B
$1.68M 0.2%
13,030
+110
+0.9% +$11.1K
MGM icon
113
MGM Resorts International
MGM
$10.9B
$1.64M 0.19%
49,204
-1,299
-3% -$39.6K
DXCM icon
114
DexCom
DXCM
$33.6B
$1.64M 0.19%
29,920
-980
-3% -$46.5K
MCD icon
115
McDonald's
MCD
$189B
$1.6M 0.19%
8,082
-200
-2% -$39.7K
LIN icon
116
Linde
LIN
$226B
$1.57M 0.18%
7,363
EEM icon
117
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$1.57M 0.18%
34,898
SPEM icon
118
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.8B
$1.56M 0.18%
41,510
+19,091
+85% +$688K
MLPA icon
119
Global X MLP ETF
MLPA
$2.37B
$1.45M 0.17%
30,667
-10,383
-25% -$484K
GILD icon
120
Gilead Sciences
GILD
$184B
$1.44M 0.17%
22,175
-100
-0.4% -$6.51K
SLB icon
121
SLB Ltd
SLB
$79.5B
$1.43M 0.17%
35,550
+21,265
+149% +$759K
XLRE icon
122
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.49B
$1.4M 0.16%
36,143
+24,411
+208% +$944K
HSY icon
123
Hershey
HSY
$37.2B
$1.39M 0.16%
9,473
-100
-1% -$14.8K
STZ icon
124
Constellation Brands
STZ
$23B
$1.39M 0.16%
7,320
-150
-2% -$28.3K
VFC icon
125
VF Corp
VFC
$5.46B
$1.38M 0.16%
13,796

Similar funds

Wealthstreet Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Wealthstreet Investment Advisors held 353 positions worth $857M, up 9.5% from $783M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wealthstreet Investment Advisors's Q4 2019 filing shows 18 new, 76 increased, 99 reduced and 3 closed positions. Its largest new stake was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K. The largest sale was Celgene Corp, an estimated $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Wealthstreet Investment Advisors's largest Q4 2019 buy was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K.
  • Wealthstreet Investment Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $8.44M increase.
  • Wealthstreet Investment Advisors's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $661K.
  • Wealthstreet Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.8M.
  • Wealthstreet Investment Advisors's ten largest holdings make up 25% of its $857M portfolio in Q4 2019.
  • Wealthstreet Investment Advisors opened 18 new positions and closed 3 in Q4 2019.
  • Wealthstreet Investment Advisors's portfolio value rose 9.5% quarter-over-quarter to $857M.

Based on Wealthstreet Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.